Lincoln National Corporation (LNC)

Orchard Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Premiums & Annuity Revenue	6,557	6,425	3,672	6,087	5,617	5,372
Total Interest & Dividend Income	5,770	5,525	5,879	5,515	6,111	5,510
Gain (Loss) on Sale of Investments	-265	-268	-897	-15	659	-78
Other Revenue	5,974	6,286	3,048	7,338	5,340	6,635
Total Revenue	18,036	17,968	11,702	18,925	17,715	17,439
Revenue Growth (YoY)	31.97%	53.55%	-38.17%	6.83%	1.58%	1.05%
Policy Benefits	11,542	11,361	9,386	11,356	11,432	11,600
Policy Acquisition & Underwriting Costs	1,747	2,003	1,901	1,837	1,886	5,064
Amortization of Goodwill & Intangibles	96	96	44	65	50	-
Selling, General & Administrative	2,957	2,957	3,069	2,943	2,822	-
Other Operating Expenses	620	602	501	562	447	-
Total Operating Expenses	16,962	17,019	14,901	16,763	16,637	16,664
Operating Income	1,074	949	-3,199	2,162	1,078	775
Interest Expense	-236	-336	-331	-283	-270	-284
Other Non Operating Income (Expenses)	500	2,867	2,416	480	3,936	-
EBT Excluding Unusual Items	1,338	3,480	-1,114	2,359	4,744	491
Merger & Restructuring Charges	-40	-40	-34	-	-101	-68
Impairment of Goodwill	-	-	-	-634	-	-
Gain (Loss) on Sale of Assets	-2	582	-	-	-	-
Pretax Income	1,296	4,022	-1,148	1,725	4,643	423
Income Tax Expense	160	747	-396	367	865	-76
Earnings From Continuing Ops.	1,136	3,275	-752	1,358	3,778	499
Net Income	1,136	3,275	-752	1,358	3,778	499
Preferred Dividends & Other Adjustments	91	91	82	-	-	-
Net Income to Common	1,045	3,184	-834	1,358	3,778	499
Net Income Growth	-34.49%	-	-	-64.05%	657.11%	-43.68%
Shares Outstanding (Basic)	173	171	170	171	187	194
Shares Outstanding (Diluted)	174	173	170	173	190	194
Shares Change (YoY)	1.77%	2.07%	-1.82%	-8.93%	-2.48%	-3.78%
EPS (Basic)	6.06	18.66	-4.92	7.94	20.16	2.58
EPS (Diluted)	6.00	18.41	-4.92	7.79	19.96	2.56
EPS Growth	-37.64%	-	-	-60.99%	679.86%	-41.55%
Dividend Per Share	1.800	1.800	1.800	1.800	1.710	1.620
Dividend Growth	-	-	-	5.26%	5.56%	7.29%
Operating Margin	5.96%	5.28%	-27.34%	11.42%	6.08%	4.44%
Profit Margin	5.79%	17.72%	-7.13%	7.18%	21.33%	2.86%
EBITDA	-	958	-3,190	2,185	1,116	828
EBITDA Margin	-	5.33%	-27.26%	11.55%	6.30%	4.75%
D&A For EBITDA	-	9	9	23	38	53
EBIT	1,074	949	-3,199	2,162	1,078	775
EBIT Margin	5.96%	5.28%	-27.34%	11.42%	6.08%	4.44%
Effective Tax Rate	12.35%	18.57%	-	21.27%	18.63%	-
Revenue as Reported	17,908	18,442	11,645	18,810	17,715	17,439

Updated Jul 31, 2025. Source: S&P Global Market Intelligence. Insurance template. Financial Sources.

SEC Filings: 10-K · 10-Q